Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma-Reference-Cited by-同舟云学术

Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma

Published:2018-04-18 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Rohr-Udilova Nataliya,Klinglmüller Florian,Schulte-Hermann Rolf,Stift Judith,Herac Merima,Salzmann Martina,Finotello Francesca^ORCID,Timelthaler Gerald,Oberhuber Georg,Pinter Matthias,Reiberger Thomas^ORCID,Jensen-Jarolim Erika,Eferl Robert,Trauner Michael

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-24437-5.pdf

Reference39 articles.

1. Jemal, A. et al. Global cancer statistics. CA Cancer Journal for Clinicians 61, 69–90, https://doi.org/10.3322/caac.20107 (2011).

2. Llovet, J. M., Villanueva, A., Lachenmayer, A. & Finn, R. S. Advances in targeted therapies for hepatocellular carcinoma in the genomic era. Nature reviews. Clinical oncology 12, 408–424, https://doi.org/10.1038/nrclinonc.2015.103 (2015).

3. Dyck, L. & Mills, K. H. G. Immune checkpoints and their inhibition in cancer and infectious diseases. Eur J Immunol. https://doi.org/10.1002/eji.201646875 (2017).

4. Kudo, M. Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials. Oncology 92(Suppl 1), 50–62, https://doi.org/10.1159/000451016 (2017).

5. Hato, T., Goyal, L., Greten, T. F., Duda, D. G. & Zhu, A. X. Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions. Hepatology 60, 1776–1782, https://doi.org/10.1002/hep.27246 (2014).

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti–programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinoma;Oncology and Translational Medicine;2024-06-03

2. Deconvolution analysis identified altered hepatic cell landscape in primary sclerosing cholangitis and primary biliary cholangitis;Frontiers in Medicine;2024-05-15

3. Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances;Frontiers in Immunology;2024-02-15

4. Construction and validation of a joint diagnosis model based on random forest and artificial intelligence network for hepatitis B-related hepatocellular carcinoma;Translational Cancer Research;2024-02

5. A prognostic exosome-related long non-coding RNAs risk model related to the immune microenvironment and therapeutic responses for patients with liver hepatocellular carcinoma;Heliyon;2024-01